| Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing VN Giri, R Hartman, M Pritzlaff, C Horton, SW Keith JCO Precision Oncology 6 (1), e2200234, 2022 | 17 | 2022 |
| TARGET: A Randomized, Noninferiority Trial of a Pretest, Patient-Driven Genetic Education Webtool Versus Genetic Counseling for Prostate Cancer Germline Testing S Loeb, SW Keith, HH Cheng, AE Leader, L Gross, T Sanchez Nolasco, ... JCO Precision Oncology 8, e2300552, 2024 | 1 | 2024 |
| Timing of Immune-Related Adverse Events among Older Adults with Melanoma, a Population-based Study S Sharma, N Nikita, A Shaver, K Gandhi, R Hartman, S Keith, J Johnson, ... Journal of Geriatric Oncology 14 (8), S3, 2023 | | 2023 |
| Technology-enhanced acceleration of germline evaluation for therapy (TARGET): Results of a randomized controlled trial of a pretest patient-driven webtool vs. genetic … VN Giri, SW Keith, HH Cheng, A Leader, L Gross, T Sanchez Nolasco, ... Journal of Clinical Oncology 41 (16_suppl), 10598-10598, 2023 | | 2023 |
| Factors related to men’s experience with prostate cancer germline testing. VN Giri, L Gross, R Hartman, A Leader, YE Whang, A Couvillon, ... Journal of Clinical Oncology 41 (6_suppl), 128-128, 2023 | | 2023 |
| Mutation spectrum and rates of variants of uncertain significance among African American males undergoing prostate cancer germline testing: Need for equity in genetic testing. VN Giri, RL Hartman, M Pritzlaff, SW Keith Journal of Clinical Oncology 40 (16_suppl), 10502-10502, 2022 | | 2022 |
| Patient-reported outcomes among males undergoing prostate cancer germline testing: Interim results from the Prostate Cancer Genetic Risk, Experience, and Support Study … VN Giri, RL Hartman, L Gross, SW Keith Journal of Clinical Oncology 40 (16_suppl), 10595-10595, 2022 | | 2022 |
